| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/18/2002 | EP0592582B1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 09/18/2002 | CN1370238A Human poly(ADP-ribose) polymerase 2 materials and methods |
| 09/18/2002 | CN1370231A CASB618 polynucleotides and polypeptides and their use |
| 09/18/2002 | CN1370181A Effectors of dipeptidyl peptidase IV for topical use |
| 09/18/2002 | CN1370175A Dithiepino [6,5-b] pyridines, and related compsns. and methods |
| 09/18/2002 | CN1370163A Imidazo [1,2-A] pyridine and pyrazolo [2,3-a] pyridine derivatives |
| 09/18/2002 | CN1370159A Indole derivatives and their use for treatment of osteoporosis amongst other applications |
| 09/18/2002 | CN1370154A Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/18/2002 | CN1370143A Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 09/18/2002 | CN1370083A Ninovasive genetic immnization, expression products therefrom, and uses thereof |
| 09/18/2002 | CN1370077A Vaccine against intra-cellular pathogens |
| 09/18/2002 | CN1370074A Method of treating malignancies and viral infections and improving immune function with dietary supplement |
| 09/18/2002 | CN1370068A Pharmaceutical agent comprising benzamide derivative as active ingredient |
| 09/18/2002 | CN1369561A Cell factor CK-HA and its variant with hematogenesis promoting and immunoregulating functions |
| 09/18/2002 | CN1369296A 'Jiwenning' for treating chicken pest and its preparing process |
| 09/18/2002 | CN1369271A Bee larve extract and its preparing process |
| 09/18/2002 | CN1369266A Immunodepressive medicine and its preparing process and application |
| 09/18/2002 | CN1090935C Pharmaceutical compsn. of piperidnoalkanol compounds |
| 09/18/2002 | CN1090916C Oral liquid for preventing altitude disease and its preparing process |
| 09/17/2002 | US6452052 Such as bis-(2-(3-hydroxy-butyrylamido)phenyl)-disulfide; treating allergies of the eyes, nose, skin, ear, gastrointestinal tract, airways or lung and preventing/ treating systemic mastocytosis |
| 09/17/2002 | US6452011 Process for production of piperidine derivatives |
| 09/17/2002 | US6452007 Crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine |
| 09/17/2002 | US6452001 1,4-diazepine-2-one derivatives as neurokinin antagonist |
| 09/17/2002 | US6451994 Polypeptides, polynucleotides; drug screening; diagnosing alzheimer*s, parkinson*s, huntington*s, and creutzfelt-jacob disease; amyotrophic lateral sclerosis, cystic fibrosis |
| 09/17/2002 | US6451982 Polypeptide with amino acid sequences grafted into human heavy and light chain variable regions |
| 09/17/2002 | US6451981 Inhibitor of cellular adhesion, migration or infiltration into areas of tissue damage, injury, or transplant |
| 09/17/2002 | US6451976 Bi-or multifunctional molecules based on a dendroaspin scaffold |
| 09/17/2002 | US6451839 Indole sPLA2 inhibitors |
| 09/17/2002 | US6451838 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/17/2002 | US6451829 Coumarinic compounds having IgE affecting properties |
| 09/17/2002 | US6451824 Sulfonylaminocarboxylic acids |
| 09/17/2002 | US6451812 Farnesyl protein transferase inhibitors for treating arthropathies |
| 09/17/2002 | US6451810 Amide substituted imidazoquinolines |
| 09/17/2002 | US6451804 Heteroalkylamino-substituted bicyclic nitrogen heterocycles |
| 09/17/2002 | US6451801 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 09/17/2002 | US6451522 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian cc-chemokine receptor 2, mammalian cc-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 09/17/2002 | US6451325 Vaccines; oil in water emulsion and detergent; lipophilic muramyl dipeptide immunostimulant; free of ethylene oxide-propylene oxide block copolymer |
| 09/17/2002 | US6451324 Ryegrass pollen allergen |
| 09/17/2002 | US6451320 Combined hepatitis and herpesvirus antigen compositions |
| 09/17/2002 | US6451318 Secreted proteins |
| 09/17/2002 | US6451316 Incubating t-cells and antigen presenting cells in vitro with purified complex of heat shock protein and antigen; generating cd4 cells; immunotherapy, anticarcinogenic agents |
| 09/17/2002 | US6451314 MHC conjugates useful in ameliorating autoimmunity |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451307 3′-exonuclease, production and use thereof |
| 09/17/2002 | US6451305 Methods for stimulating T cell responses to tumor cells expressing LFA-3 and a CD28 or CTLA4 ligand |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2213001C Isolated nucleic acid molecule encoding peptides which form complexes with mhc molecule hla-cw*1601 and uses thereof |
| 09/17/2002 | CA2116674C Imidazolidyl macrolides |
| 09/17/2002 | CA2095534C Avirulent microbes and uses therefor |
| 09/17/2002 | CA2048096C N-benzyl-indoles |
| 09/17/2002 | CA2047244C Genetically engineered immunoglobulins |
| 09/17/2002 | CA2020431C Aqueous liquid eyedrop composition |
| 09/14/2002 | CA2376716A1 Use of a c1 esterase inhibitor for preventing or delaying rejection of xenotransplants in mammals |
| 09/12/2002 | WO2002071064A1 Method of examining steroid-responsiveness |
| 09/12/2002 | WO2002071062A2 Diagnosis and treatment of inflammation and hyperactive immune conditions |
| 09/12/2002 | WO2002070748A2 Response of dendritic cells to a diverse set of pathogens |
| 09/12/2002 | WO2002070716A1 Allergen ole e 9 from olea europaea, recombinant dna coding for said allergen, the production and use thereof |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070665A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070548A2 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/12/2002 | WO2002070523A1 Modulators of chemokine receptor activity |
| 09/12/2002 | WO2002070516A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 09/12/2002 | WO2002070515A2 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 09/12/2002 | WO2002070514A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | WO2002070502A1 Dimeric isoflavones |
| 09/12/2002 | WO2002070500A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 09/12/2002 | WO2002070479A1 N-4-piperidinyl compounds as ccr5 modulators |
| 09/12/2002 | WO2002070468A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 09/12/2002 | WO2002070457A1 Inhibitor of monoamine uptake |
| 09/12/2002 | WO2002070010A1 Graft rejection inhibitors |
| 09/12/2002 | WO2002070007A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | WO2002070005A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 09/12/2002 | WO2002070001A2 Use of lp82 to treat hematopoietic disorders |
| 09/12/2002 | WO2002069999A1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 09/12/2002 | WO2002069985A2 Immune response potentiation |
| 09/12/2002 | WO2002069980A2 Pharmaceutically effective ginsenosides and their use |
| 09/12/2002 | WO2002069977A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | WO2002069970A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/12/2002 | WO2002069961A1 Il-8 receptor ligands-drugs for inflammatory and autoimmune diseases |
| 09/12/2002 | WO2002069949A2 Combination therapy for reduction of toxycity of chemotherapeutic agents |
| 09/12/2002 | WO2002069930A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | WO2002069926A1 Cosmetic formulations containing flavonoid derivatives |
| 09/12/2002 | WO2002069905A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders |
| 09/12/2002 | WO2002069904A2 Cd2 antagonists for treatment of autoimmune or inflammatory disease |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002047703A3 Immune system stimulation |
| 09/12/2002 | WO2002028862A3 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 09/12/2002 | WO2002028859A3 Condensed pyridoindole derivatives |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |